Ignite Creation Date:
2024-05-05 @ 11:55 AM
Last Modification Date:
2024-10-26 @ 9:16 AM
Study NCT ID:
NCT00171769
Status:
COMPLETED
Last Update Posted:
2017-02-23
First Post:
2005-09-13
Brief Title:
Atrial Fibrillation Feasibility Certoparin Trial - AFFECT
Sponsor:
Novartis
Organization:
Novartis
Conditions & Keywords Data
Conditions:
| Name |
|---|
| Persistent Nonvalvular Atrial Fibrillation |
Keywords: